Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
Clinical trial NCT01323374 · COMPLETED
Trial details
- NCT number
- NCT01323374
- Sponsor
- Chelsea Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2011-10-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.